OREM, Utah, May 27, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a leading innovator in cryogenic cooling technologies, today announced a comprehensive initiative to reduce Selling, General & Administrative (SG&A) expenses by up to 35% in the fiscal year 2025. This strategic move will be driven by integrating artificial intelligence solutions across business operations and expanding the Company's contract manufacturing relationships. "By leveraging cutting-edge AI technology and optimiz ...

SharpLink continues its online performance-based marketing company serving the U.S. sports betting and global iGaming industries Upon the closing of the Private Placement, SharpLink will adopt an Ethereum Treasury Strategy Joseph Lubin, the Founder and CEO of Consensys and Co-Founder of Ethereum, will become Chairman of the Board of Directors of the Company effective upon the closing of the private placement MINNEAPOLIS, May 27, 2025 (GLOBE NEWSWIRE) -- SharpLink Gaming, Inc. (NASDAQ:SBET) (the "Company" or ...

CARMEL, Ind., May 27, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually on Thursday, May 29, 2025. Company Webcast The webcast presentation will take place at 9 ...

SSCP Lager BidCo AB (publ) – Interim report for the period 1 January – 31 March 2025. Today SSCP Lager Bidco AB (publ) published an interim report for the first quarter, the report can be downloaded on www.logent.se or via the link below. For more information, please contact:Andrzej Kulik, CFO, telephone number: +46 738 15 67 00, andrzej.kulik@logent.se or Joel Engström, CEO, telephone number: +46 734 36 36 29, joel.engstrom@logent.se This press release was published on 27th May at CET 14:00 This informati ...

For more information, contact Media.Relations@Car-Mart.com ROGERS, Ark., May 27, 2025 (GLOBE NEWSWIRE) -- America’s Car-Mart, Inc. (Nasdaq: CRMT) announced its annual Community Fan Drive, a company tradition conducted every May and June. For over 25 years, Car-Mart has rallied its customers, associates, and partners to collect fans that are then donated to local charities chosen by each dealership. “Summer means higher temperatures, and it will be difficult for some people to stay cool and comfortable. Ever ...

NAARDEN, the Netherlands and MIAMI, May 27, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the following upco ...

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the Goldman Sachs 46th Annual Global Healthcare Conference. Nautilus’ management is scheduled to participate in a fireside chat on Tuesday, June 10, 2025, at 2:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on ...

Highly Qualified New Board Nominees Will Strengthen authID’s mission to Drive Growth and Value Creation for Shareholders 2025 Annual Meeting to be Held on June 26, 2025 DENVER, May 27, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID)(“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, is nominating four highly qualified executives to the Board of Directors (the “Board”), in addition to the nomination of existing directors, included within the 2025 P ...

- Study will assess relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine candidate against an approved mRNA comparator at 12 months - SOUTH SAN FRANCISCO, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the first patient was dosed in the 10,000-participant portion of its ongoing Phase 2b clinical trial evaluating its oral pill COVID-19 vaccine candidate. “Initiating dosing in the 10,000-participant portion of this study is a significant st ...

SHANGHAI, May 27, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (the “NMPA”) has approved two supplemental new drug applications for the ongericimab injection (a recombinant humanized anti-PCSK9 monoclonal antibody injection, trade name: JUNSHIDA (君适达® ...